Product correctly added to cart.

discount label
5-Bromo-8-nitroisoquinoline
View 3D

Biosynth logo

5-Bromo-8-nitroisoquinoline

CAS: 63927-23-1

Ref. 3D-FB42318

2gTo inquire
5gTo inquire
10gTo inquire
25gTo inquire
50gTo inquire
Estimated delivery in United States, on Monday 1 Jul 2024

Product Information

Name:
5-Bromo-8-nitroisoquinoline
Synonyms:
  • Isoquinoline, 5-bromo-8-nitro-
Description:

5-Bromo-8-nitroisoquinoline is a drug that binds to the nicotinic acetylcholine receptor and has been shown to have antifilarial activity. It also has an affinity for dopamine receptors in the brain, which may be responsible for its neurological effects. 5-Bromo-8-nitroisoquinoline is a racemic mixture of two enantiomers, one of which is more active than the other. The inactive enantiomer (5-bromo-8-nitroisoquinoline) has a lower affinity for the nicotinic acetylcholine receptor and thus does not show antifilarial activity. This drug is metabolized by liver enzymes to form hydrogenated metabolites with acanthocheilonema worms. The active enantiomer (5-bromo-8-nitroisoquinoline) inhibits dopamine release from nerve cells and prevents them from stimulating muscles, leading to paralysis of these worms

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
253.05 g/mol
Formula:
C9H5BrN2O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FB42318 5-Bromo-8-nitroisoquinoline

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".